Artificial Kidney Prize, Phase 1
Total prize amount:$3.9 Million
The KidneyX Artificial Kidney Prize is a competition to accelerate the development of artificial kidneys toward human clinical trials. Phase 1 of the Artificial Kidney Prize called for component or integrated prototype solutions that enable and advance the functionality, effectiveness, and/or reliability of artificial kidneys.
To accelerate the development of continuous kidney replacement therapies that provide transformational treatment options beyond current dialysis methods.
- For this competition, artificial kidneys could be wearable, implantable, bioengineered, developed as a xenotransplant or chimera organ, or other approaches not yet conceived.
- The competition aimed to bring these artificial kidney solutions toward human clinical trials with a greater level of maturity, functionality, and potential for patient impact than currently possible.
- The Artificial Kidney Prize is intended to stimulate the market for further kidney health innovation, drawing greater participation and capital.
Bring artificial kidney solutions closer to human clinical trials with a greater level of maturity, functionality, and potential for patient impact than currently possible